Columbia University-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Columbia University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014368
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:58
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥79,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
Columbia University (CU) is an educational service provider that offers educational and research programs. The university provides educational services and courses through its schools, departments, faculties, centers and institutes. It provides undergraduate and graduate courses in various disciplines including architecture, planning and preservation, arts, sciences, social sciences, dental medicine, engineering, law, social work, nursing and public health, among others. CU conducts research through its research institutes and centers in the areas of natural and bio-medical sciences, social sciences and humanities. The university also conducts various research and clinical programs. CU is headquartered in New York, the US.

Columbia University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Columbia University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Columbia University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Columbia University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Columbia University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Columbia University, Medical Devices Deals, 2011 to YTD 2017 11
Columbia University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Columbia University, Pharmaceuticals & Healthcare, Deal Details 14
Partnerships 14
Verge Genomics Enters into Agreement with Columbia University, Massachusetts General Hospital, University of Southern California, and University of Michigan 14
Atossa Genetics Enters into Agreement with Columbia University Medical Center 15
Biogen Idec Enters into Research Agreement with Columbia University Medical Center 16
Cancer Genetics Enters into Co-Development Agreement with Columbia University Medical Center 17
CSPC ZhongQi Pharma to Enter into Co-Development Agreement with Columbia University 18
Genia Technologies Enters Into Agreement With Columbia University And Harvard Medical To Develop NanoTag DNA Sequencing Technology 19
Sanofi-aventis Enters Into Research Collaboration With Columbia University 20
Licensing Agreements 21
Lin Bioscience Enters into Licensing Agreement with Columbia University and Memorial Sloan Kettering Cancer Center 21
Lin Bioscience Enters into Licensing Agreement with Columbia Technology Ventures 22
Fortress Biotech Enters into Licensing Agreement with Columbia University 23
Heat Biologics Enters into Licensing Agreement with Columbia University 24
vTv Therapeutics Enters into Licensing Agreement with Columbia University 25
ALSP Enters Into Licensing Agreement with Columbia University 26
iCura Vision Enters into Licensing Agreement with Columbia Technology Ventures 27
Sapience Therapeutics Enters into Licensing Agreement with Columbia University 28
Vor BioPharma Enters into Licensing Agreement with Columbia University 29
Apeiron Biologics Enters into Licensing Agreement with Columbia University 30
Kyras Therapeutics Enters into Agreement with Columbia University 31
Roche Diagnostics Enters Into Licensing Agreement With Arizona Technology And Columbia University 32
China Institute of Strategy and Management Lanmeng Investment Enters Into Licensing Agreement With Columbia University 33
Columbia University Enters Into Licensing Agreement With Alkeus Pharma 34
Columbia University – Key Competitors 35
Columbia University – Key Employees 36
Columbia University – Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 39
Government and Public Interest 39
Nov 16, 2017: Irving Family’s $700 Million Bequest to Columbia University and NewYork-Presbyterian Sets Stage for Dramatic Advances in Cancer Research and Care 39
Nov 08, 2017: Mechanical heart valve often the safest choice 41
Oct 16, 2017: Cancer Researchers at Wake Forest Baptist Receive $9 Million Grant to Study Aggressive Brain Cancer 43
Oct 02, 2017: DSI Professor Conducts Research to Combat Pancreatic Cancer 44
Sep 27, 2017: NIH announces centers for myalgic encephalomyelitis/chronic fatigue syndrome research 45
Sep 27, 2017: NIH Awards $9.6 Million Grant to Columbia for a Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Collaborative Research Center 47
Sep 08, 2016: New Vaccination Strategies Successfully Coach Immune System to Make Powerful HIV-Neutralizing Antibodies 49
Jul 18, 2016: Toxic Alzheimer’s Protein Spreads Through Brain Via Extracellular Space 51
Jul 14, 2016: Columbia University Awarded $58.4 Million to Accelerate Development of New Therapies 52
Apr 21, 2016: Columbia Engineering-led Team Advances Single Molecule Electronic DNA Sequencing—A Future Platform for Precision Medicine 54
Feb 17, 2016: Cancer Study is ‘Paradigm Shift’ in Cause of Tumor Formation 56
Jan 21, 2016: Columbia Neuroscientists Develop New Tools to Safely Trace Brain Circuits 57
Appendix 58
Methodology 58
About GlobalData 58
Contact Us 58
Disclaimer 58

List of Tables
Columbia University, Pharmaceuticals & Healthcare, Key Facts 2
Columbia University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Columbia University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Columbia University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Columbia University, Deals By Therapy Area, 2011 to YTD 2017 9
Columbia University, Medical Devices Deals, 2011 to YTD 2017 11
Columbia University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12
Verge Genomics Enters into Agreement with Columbia University, Massachusetts General Hospital, University of Southern California, and University of Michigan 14
Atossa Genetics Enters into Agreement with Columbia University Medical Center 15
Biogen Idec Enters into Research Agreement with Columbia University Medical Center 16
Cancer Genetics Enters into Co-Development Agreement with Columbia University Medical Center 17
CSPC ZhongQi Pharma to Enter into Co-Development Agreement with Columbia University 18
Genia Technologies Enters Into Agreement With Columbia University And Harvard Medical To Develop NanoTag DNA Sequencing Technology 19
Sanofi-aventis Enters Into Research Collaboration With Columbia University 20
Lin Bioscience Enters into Licensing Agreement with Columbia University and Memorial Sloan Kettering Cancer Center 21
Lin Bioscience Enters into Licensing Agreement with Columbia Technology Ventures 22
Fortress Biotech Enters into Licensing Agreement with Columbia University 23
Heat Biologics Enters into Licensing Agreement with Columbia University 24
vTv Therapeutics Enters into Licensing Agreement with Columbia University 25
ALSP Enters Into Licensing Agreement with Columbia University 26
iCura Vision Enters into Licensing Agreement with Columbia Technology Ventures 27
Sapience Therapeutics Enters into Licensing Agreement with Columbia University 28
Vor BioPharma Enters into Licensing Agreement with Columbia University 29
Apeiron Biologics Enters into Licensing Agreement with Columbia University 30
Kyras Therapeutics Enters into Agreement with Columbia University 31
Roche Diagnostics Enters Into Licensing Agreement With Arizona Technology And Columbia University 32
China Institute of Strategy and Management Lanmeng Investment Enters Into Licensing Agreement With Columbia University 33
Columbia University Enters Into Licensing Agreement With Alkeus Pharma 34
Columbia University, Key Competitors 35
Columbia University, Key Employees 36
Columbia University, Subsidiaries 37

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Columbia University-製薬・医療分野:企業M&A・提携分析(Columbia University - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆